Skynor Medical

What Skynor Medical does

Skynor Medical (Shanghai) Co., Ltd. is a Chinese medical device company founded in August 2014 and headquartered in the Shanghai International Medical Valley. The company designs, develops, and commercializes minimally invasive vascular interventional devices targeting two clinical segments: neurovascular interventions for acute ischemic stroke and peripheral vascular interventions for arterial and venous disease. Its portfolio spans approximately 11 commercialized and pipeline products organized under three series — neuro-intervention (SkyFlow thrombectomy stent retriever, SkySurfer distal access catheter, SkyGuard balloon guide catheter, SkyWay microcatheter, SkyLoach intracranial balloon dilatation catheter, SkyDragon thrombus aspiration catheter), peripheral intervention (SkyNova peripheral vascular stent, Hydrus PTA balloon dilatation catheter, Hydrus peripheral balloon dilatation catheter), and an access series (SkyKeeper embolic protection device, SkyManna infusion catheter). Underlying technology centers on catheter-based delivery mechanics, including closed-ring double-helix stent geometry (SkyFlow), Ni-Ti coil multi-segment shafts (SkySurfer), large-lumen thin-wall balloon construction (SkyGuard), rapid-exchange intracranial balloon design (SkyLoach), and 0.071-inch large-cavity aspiration (SkyDragon); the company owns 28 patents and reports 15+ additional products in the application stage.

The company generates revenue from hardware sales of its disposable interventional devices to hospitals, catheterization labs, interventional radiology departments, and stroke centers. It operates a direct sales force covering 29 provinces in China and is building international distribution networks in Southeast Asia, EMEA, and Latin America via channel partners, with CE-marked products supporting European and other international commercialization. Key regulatory milestones include NMPA approvals for the Hydrus products (January 2021), CE marks for the full mechanical thrombectomy portfolio and the Hydrus balloon dilatation catheter (May 2021), and ISO 13485:2016 certification from TUV SUD (June 2023). Skynor has raised cumulative funding of approximately RMB 100 million+ in equity across angel (2014), Pre-A (2016), Series A (2018–2019 led by Sinopharm Capital), Series B (2021 ~RMB 100 million led by Zeyue Capital, Chuangban Investment, and Anlong Fund), and additional rounds in 2022 (~$14.5M) and 2023 (~$15M) — the latter two from Pudong Venture Capital, Zhangjiang Haocheng, Suxin, and Zhangjiang Torch Venture Capital.

Name

Skynor Medical

Legal name

Skynor Medical (Shanghai) Co., Ltd

Website

https://en.skynormedical.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

1–10 employees

Short description

Skynor Medical is a Shanghai-based medical device company developing and commercializing minimally invasive vascular interventional devices, including stent retrievers, balloon and aspiration catheters, and microcatheters, for acute ischemic stroke and peripheral vascular disease treatment in China and international markets.

Ownership category

akta.pro rank

Product category

Vascular Interventional Medical Devices (Neurovascular and Peripheral)

NAICS

Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Thrombectomy, Embolic Protection & Stroke Intervention Devices (HLAHAFAJ)

akta.pro secondary industries

Peripheral Vascular Intervention (PAD Stents, Balloons, Atherectomy) (HLAHAFAE), Stroke & Vascular Neurology (HLAKAIAG), Interventional Cardiology (PCI/Structural Heart) (HLAKABAB)

Keywords

• Vascular interventional devices
• Neurovascular thrombectomy products
• Peripheral vascular stents
• Balloon dilatation catheters
• Minimally invasive stroke devices

Headquarters

HQ city

Shanghai

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Operations, Marketing or Sales, Personnel, Infrastructure

Revenue model

1. Vascular Interventional Medical Devices: Skynor Medical generates revenue through the sale of vascular interventional medical devices including thrombectomy devices, balloon catheters, microcatheters, stent systems, and access catheters for neurovascular and peripheral vascular interventions. Both product lines (neurovascular and peripheral) contribute to revenue with products at various stages of commercialization in China and internationally.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

Skynor Medical designs, develops, manufactures and sells minimally invasive vascular interventional devices used by hospitals and interventional physicians to treat acute ischemic stroke and peripheral vascular disease. Its portfolio spans neuro-intervention products (stent retrievers, distal access catheters, balloon guide catheters, microcatheters, intracranial balloon dilatation catheters, thrombus aspiration catheters), peripheral intervention products (self-expanding peripheral stents and PTA balloon dilatation catheters), and an access series (embolic protection devices and infusion catheters). The company sells primarily to hospitals and medical centers in China and internationally.

Product overview

Skynor Medical is a medical device company specializing in vascular interventional devices for stroke and peripheral vascular disease treatment. The company offers two main product lines: Neuro-intervention products (SkyFlow Thrombectomy Device, SkySurfer Distal Access Catheter, SkyGuard Balloon Guide Catheter, SkyWay Microcatheter, SkyLoach Intracranial Balloon Dilatation Catheter, SkyDragon Thrombus Aspiration Catheter) for acute ischemic stroke treatment, and Peripheral intervention products (SkyNova Peripheral Vascular Stent System, Hydrus PTA Balloon Dilatation Catheter, Hydrus Peripheral Balloon Dilatation Catheter) for peripheral arterial and venous disease. Additionally, the Access series includes SkyKeeper Embolic Protection Device and SkyManna Infusion Catheter for supporting interventional procedures. The portfolio provides comprehensive treatment solutions for patients with stroke and peripheral vascular diseases, with products carrying CE mark approval for European market and NMPA approval for China market.

Differentiator

Problem solved

Functional benefit

Products and services

• SkyFlow Thrombectomy Device Stent retriever thrombectomy device indicated for acute ischemic stroke caused by large artery occlusions. Features closed-ring structure with double helix design, dual-size cells for enhanced clot capture, multi-radiopaque markers and improved stent flexibility. Used by interventional neuroradiologists in hospital cath labs and stroke centers.
• SkySurfer Distal Access Catheter Distal access catheter for introducing interventional or diagnostic instruments into cerebral and peripheral blood vessels and for aspiration of thrombus and debris. Features large catheter lumen, multi-segment technology with Ni-Ti coil design, optimal flexibility for tortuous vessels, stainless steel reinforcing layer for pushability and combined aspiration function. Used by interventional specialists in neurovascular and peripheral procedures.
• SkyGuard Balloon Guide Catheter Balloon guide catheter that facilitates insertion and guidance of intravascular catheters in neurovascular systems. Features large lumen with thin wall design, high-compliance balloon for blood flow occlusion, multi-segment design for tortuous anatomy, reinforced braided structure for pushability and microcatheter / distal access catheter compatibility. Used in hospital neurointerventional procedures.
• SkyWay Microcatheter Microcatheter for the introduction of non-liquid interventional devices such as stents and flow diverters, and infusion of diagnostic or therapeutic agents into neuro, peripheral and coronary vasculature. Features multi-segment ultra-flex design, stainless steel reinforcement, intracranial aneurysm and stent retriever compatibility and super slippery hydrophilic coating.
• SkyLoach Intracranial Balloon Dilatation Catheter Intracranial balloon dilatation catheter for improving intracranial perfusion in patients with intracranial stenosis. Features rapid-exchange design, semi-compliant small-diameter balloon, optimal distal compliance and crossing ability, high proximal pushability and super slippery hydrophilic coating for traceability.
• SkyDragon Thrombus Aspiration Catheter Thrombus aspiration catheter for revascularization in patients with acute ischemic stroke secondary to intracranial large vessel occlusion within 8 hours of symptom onset. Features 0.071 inch large cavity suction to shorten operation time, distal nitinol for compliance and kink resistance, proximal stainless steel for support and multiple specifications (4F/5F/6F).
• SkyNova Peripheral Vascular Stent System Self-expanding nitinol stent system for treatment of peripheral vascular stenosis and occlusion of iliac artery and femoral artery of the lower limbs. Features helical construction for optimal compliance and kink resistance, end closed-ring design for deploy accuracy, ultra-long stent option with thin wall and low coefficient of friction and a delivery system with exceptional manipulation and stable deployment.
• Hydrus PTA Balloon Dilatation Catheter Balloon dilatation catheter for percutaneous transluminal angioplasty (PTA) of peripheral arteriovenous vascular occlusion or stenosis, native or synthetic arteriovenous dialysis fistula occlusion, and post-dilation of balloon-expandable and self-expanding stents in the peripheral vasculature. Compatible with 0.014/0.018 inch guide wire.
• Hydrus Peripheral Balloon Dilatation Catheter Balloon dilatation catheter for peripheral vascular applications. Compatible with 0.035 inch guide wire, OTW coaxial double-lumen catheter for enhanced pushability, broad balloon size range, ultra-slippery hydrophilic coating up to 350mm for traceability, durable balloon with high rated burst pressure and excellent manipulation.
• SkyKeeper Embolic Protection Device Embolic protection device used to protect patients from distal embolization during vascular interventions including peripheral vessels and carotid arteries. Features efficient thrombus capture, visualization and precise positioning, with guidewire moving independently of the filter screen for safe and stable operation.
• SkyManna Infusion Catheter Infusion catheter for liquid administration of thrombolytic agents and contrast agents into peripheral blood vessels. Features multi-angle micro-hole design for uniform and powerful injection.

Quantifiable outcome

• Stroke kills 1.7 million people every year in China, making it the first cause of death among Chinese residents
• +4 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Scale indicators8 records

Direct peers

• Penumbra: US-listed leader in mechanical thrombectomy for acute ischemic stroke (Indigo and RED systems). Penumbra is the primary global benchmark in the same neurovascular intervention category as Skynor's SkyFlow and SkyDragon devices.
• Stryker (Neurovascular): Through its Neurovascular division (formerly Codman Neuro), Stryker markets the Trevo stent retriever and balloon guide catheters that directly compete with SkyFlow, SkySurfer and SkyGuard.
• Cerenovus (Johnson & Johnson MedTech): J&J's neurovascular franchise offers the EmboTrap and CEREBLATE platforms for stroke thrombectomy, competing head-to-head with Skynor's neurovascular suite across CE-marked and NMPA-approved markets.
• MicroPort Scientific: Shanghai-headquartered Chinese medtech with vascular interventional products including stent retrievers and peripheral devices, directly competing with Skynor in both domestic hospital channels and overlapping CE-marked geographies.
• Zylox-Tonbridge Medical: Chinese neurovascular and peripheral interventional device company with a comparable dual-portfolio strategy (thrombectomy and peripheral PTA balloons), sharing Skynor's NMPA/CE dual-market commercial approach.
• Wallaby Medical: Emerging Chinese neurovascular OEM with the Avenir coil and a stent-retriever product line, directly competing with Skynor in China and international markets with similar portfolio breadth.

Broad incumbents

• Medtronic: Global medtech incumbent with the Solitaire stent retriever and a broad peripheral vascular portfolio (IN.PACT Admiral, VenaSeal) that overlaps with both Skynor's neurovascular and peripheral product lines.

Emerging players

• Rapid Medical: Israel-based developer of neurovascular devices including the Tigertriever and Comaneci adjustable stent systems, competing in the same acute ischemic stroke intervention category with differentiated adjustable-mesh technology.
• InspireMD: Carotid and neurovascular embolic protection specialist whose CGuard device overlaps with Skynor's SkyKeeper embolic protection device and carotid intervention strategy.

Regional players

• Acandis: German neurovascular device manufacturer (APERIO, Thrombestentriever) competing primarily in EMEA CE-marked markets, similar regulatory profile to Skynor's CE-approved portfolio.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xtwitter.com/skynormedical
• LinkedInlinkedin.com/company/skynor-medical

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds3 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Skynor Medical